Group 1 - Ningde Times participated in the completion of the Zeyuan Fund, with a total scale of 10.128 billion yuan, increasing by 50.42% from the previous announcement [3] - Zhongjin Gold's controlling shareholder plans to inject four companies into the company to resolve competition issues, including acquiring stakes in Inner Mongolia Jintao and others [4][5] - Keli Yuan plans to invest an additional 500 million yuan in a storage industry fund, increasing its total investment to 700 million yuan [6] Group 2 - China Shenhua intends to acquire 7.43% of the National Energy Group Financial Company for 2.929 billion yuan, which is expected to increase its net profit by 97 million yuan [7] - Weir Shares plans to issue H-shares and list on the Hong Kong Stock Exchange [8] - Hualan Shares is establishing a joint venture for Tibetan medicinal baths and plaster products, with a registered capital of 7 million yuan [15] Group 3 - Yunnan Copper plans to acquire 40% of Liangshan Mining through a share issuance, with the stock resuming trading on May 26 [10] - Ruishun Technology's subsidiary plans to establish a joint venture in Malaysia to provide automation solutions [11] - ST Quanwei's stock will be subject to additional risk warnings due to ongoing litigation involving a subsidiary [12] Group 4 - Hengfeng Information's controlling shareholder has terminated the agreement to transfer part of the company's shares, with no impact on control [13] - Huadian Technology's subsidiary has not yet commenced substantial construction on a polyurethane new materials project [14] - ST Yinjian will remove the delisting risk warning and some other risk warnings, changing its stock name [38] Group 5 - China Tonghao won approximately 3.789 billion yuan in contracts in the rail transit market from March to April [39] - Intercontinental Oil and Gas plans to invest about 848 million USD in the Iraq South Basra project [40][41] - Jiaying Pharmaceutical's subsidiary signed a contract for the development of a traditional Chinese medicine innovation project [42] Group 6 - Ruidong Intelligent signed a strategic cooperation agreement with Shunde Vocational and Technical College to enhance collaboration in technology [43] - Jiaojian Co. won a bid for a drainage project worth 225 million yuan [44] - Hengshun Vinegar's controlling shareholder plans to increase its stake in the company by 50 to 100 million yuan [45]

Core Viewpoint - *ST Chuntian received a warning letter from the Qinghai Securities Regulatory Bureau for failing to disclose its relationship with Yibin Tinghua and related transactions, violating information disclosure regulations [1][2]. Group 1: Regulatory Actions - The company was ordered to correct its actions due to non-disclosure of its relationship with Yibin Tinghua Wine Industry Development Co., Ltd. and related transactions [1][2]. - Four senior executives, including Chairman Zhang Xuefeng and actual controller Xiao Rong, received warning letters for their roles in the violations [1][2]. Group 2: Relationship with Yibin Tinghua - Yibin Tinghua is identified as a related entity to *ST Chuntian, as it is the producer of the company's alcoholic products, and the company has made advance payments to Yibin Tinghua for product procurement [2]. - The company failed to disclose the related party transactions and did not follow the necessary approval procedures, violating multiple provisions of the Information Disclosure Management Measures [2]. Group 3: Previous Concerns and Responses - There were previous concerns regarding potential benefit transfers to Yibin Tinghua, which the company denied in a response to the Shanghai Stock Exchange [4]. - The company stated that its collaboration with Yibin Tinghua was based on resource complementarity within the industry chain, and it emphasized that the advance payments were reasonable and related to its main business operations [5].

Core Viewpoint - The company *ST Chuntian (600381.SH) has received regulatory measures from the China Securities Regulatory Commission (CSRC) for failing to disclose related party transactions and relationships with Yibin Tinghua Wine Industry Development Co., Ltd. [1][2] Group 1: Regulatory Actions - The CSRC's Qinghai Regulatory Bureau issued a decision on May 23, 2025, requiring *ST Chuntian to rectify its actions and issued warning letters to key executives including Zhang Xuefeng, Xiao Rong, Wang Lin, and Chen Ding [1][2] - The company was found to have made prepayments to Yibin Tinghua for product purchases without disclosing the related party relationship and transaction details [1] Group 2: Violations and Responsibilities - *ST Chuntian's actions violated multiple provisions of the "Management Measures for Information Disclosure of Listed Companies" [2] - Key executives, including the chairman and financial director, were held primarily responsible for the violations, with specific articles of the regulations cited against them [2]

根据《上市公司信息披露管理办法》(证监会令第 40 号)第五十九条、《上市公司 信息披露管理办法》(证监会令第 182 号)第五十二条的规定，我局决定对青海春天采 取责令改正的行政监管措施，对张雪峰、肖融、王林、陈定采取出具警示函的行政监 管措施，并记入证券期货市场诚信档案。 青海春天应在收到本监督管理措施后 30 日内予以改正并提交书面整改报告。 股票代码：600381 股票简称：*ST 春天 公告编号：2025-024 青海春天药用资源科技股份有限公司 关于收到中国证券监督管理委员会青海监管局警示函的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 青海春天药用资源科技股份有限公司（以下简称"公司"）于 2025 年 5 月 23 日收 到中国证券监督管理委员会青海监管局青证监措施字[2025]1 号《关于对青海春天药用 资源科技股份有限公司采取责令改正、对张雪峰、肖融、王林、陈定出具警示函措施 的决定》，现将内容公告如下： "青海春天药用资源科技股份有限公司、张雪峰、肖融、王林、陈定： 宜宾听花酒业发展有限责任公司( ...

Core Viewpoint - The company *ST Chuntian (600381.SH) has received regulatory measures from the China Securities Regulatory Commission (CSRC) for failing to disclose related party transactions and relationships with Yibin Tinghua Wine Industry Development Co., Ltd. [1][2] Group 1: Regulatory Actions - The CSRC's Qinghai Regulatory Bureau issued a decision on May 23, 2025, requiring *ST Chuntian to rectify its actions and issued warning letters to key executives including Chairman Zhang Xuefeng and others [1][2] - The company was found to have made prepayments to Yibin Tinghua for product purchases without disclosing the related party relationship and transaction details [1][2] Group 2: Violations and Responsibilities - *ST Chuntian violated multiple provisions of the Information Disclosure Management Measures, specifically Articles 2, 48, and 41 of the relevant regulations [2] - Key executives, including Zhang Xuefeng, actual controller and former director Xiao Rong, financial director Wang Lin, and board secretary Chen Ding, were held primarily responsible for the violations [2]

股东会召开日期：2025年6月3日 本次股东会采用的网络投票系统：上海证券交易所股东大会网络投票系 统 证券代码：600381 证券简称：*ST 春天 公告编号：2025-023 青海春天药用资源科技股份有限公司 关于召开2024年年度股东会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (四)现场会议召开的日期、时间和地点 召开的日期时间：2025 年 6 月 3 日 14 点 30 分 召开地点：青海省西宁市城北区生物园区经二路 12 号 4 楼会议室 (一)股东会类型和届次 2024年年度股东会 (二)股东会召集人：董事会 (三)投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合的方 式 (五)网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 6 月 3 日 至2025 年 6 月 3 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东会召开当日的交易时间段，即 9 ...

股票代码：600381 股票简称：*ST 春天 公告编号：2025-022 2025 年 5 月 8 日，公司股票再次涨停。截至 2025 年 5 月 8 日收盘，公司股价剔除 大盘整体因素后的实际波动幅度较大。公司特别提醒广大投资者注意二级市场交易风 险，理性决策，审慎投资。 二、生产经营风险 公司于 2025 年 4 月 30 日披露了《2025 年第一季度报告》，2025 年第一季度营业 收入为 8,355.91 万元，同比减少 1.11%；2025 年第一季度归属于上市公司股东的净利 润为 891.81 万元、归属于上市公司股东扣除非经常性损益后的净利润为 904.59 万元。 目前，公司生产经营情况正常，不存在影响公司股票交易价格大幅波动的重大事项。 三、其他风险警示风险 公司 2024 年度的利润总额、净利润或者扣除非经常性损益后的净利润孰低者为负 值且扣除与主营业务无关的业务收入和不具备商业实质的收入后的营业收入低于 3 亿 元，根据《上海证券交易所股票上市规则》第 9.3.2 条（一）规定，公司股票已于 2025 年 4 月 30 日被实施退市风险警示。 青海春天药用资源科技股份有限公司 关于 ...

股票代码：600381 股票简称：*ST 春天 公告编号：2025-021 青海春天药用资源科技股份有限公司 关于股票交易异常波动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 青海春天药用资源科技股份有限公司（以下简称"公司"）股票交易在 2025 年 4 月 30 日、5 月 6 日、5 月 7 日连续 3 个交易日内日收盘价格涨幅偏离值累计达到 12%， 属于股票交易异常波动。 经公司自查及向公司控股股东、实际控制人发函核实、确认，截至本公告披露 日，除公司已披露事项外，不存在其它应披露而未披露的重大事项。 公司 2024 年度的利润总额、净利润或者扣除非经常性损益后的净利润孰低者 为负值且扣除与主营业务无关的业务收入和不具备商业实质的收入后的营业收入低于 3 亿元，根据《上海证券交易所股票上市规则》第 9.3.2 条（一）规定，公司股票已 于 2025 年 4 月 30 日被实施退市风险警示。请广大投资者理性投资，注意股票二级市 场的交易风险。 一、股票交易异常波动的具体情况 公司股票交易在 2 ...

对青海春天药用资源科技股份有限公司 《问询函》的回复 西藏荣恩科技有限公司 对青海春天药用资源科技股份有限公司 《问询函》的回复 青海春天药用资源科技股份有限公司: 本人已收到贵司关于股票交易异常波动的《问询函》,并就该《问 询函》所关注事项回复、确认如下: 截至本回复日,本人不存在买卖贵公司股票、不存在涉及贵公司 的应披露而未披露的重大事项,包括但不限于筹划重大资产重组、股 份发行、债务重组、业务重组、资产剥离和资产注入等重大事项。 青海春天药用资源科技股份有限公司: 贵公司关于股票交易异常波动的《问询函》我公司已收悉。我公 司就该《问询函》所关注事项回复、确认如下: 截至本回函日,我公司不存在其他买卖贵公司股票的情况、不存 在涉及贵公司的应披露而未披露的重大事项,包括但不限于筹划重大 资产重组、股份发行、债务重组、业务重组、资产剥离和资产注入等 重大事项。 专此回复。 专此回复。 回复人:肖融 2025年5月7日 ...

Market Overview - The Shanghai Composite Index closed at 3342.67 points, above the annual line, with a gain of 0.80% [1] - The total trading volume of A-shares reached 15050.72 billion yuan [1] Stocks Breaking Annual Line - A total of 98 A-shares have surpassed the annual line today, with notable stocks including Jinpu Titanium, Sanxiang Impression, and Houpu Co., which have deviation rates of 9.12%, 8.94%, and 7.94% respectively [1] - Stocks with smaller deviation rates that just crossed the annual line include ChuanTou Energy, Hongta Securities, and Jinbin Development [1] Top Stocks by Deviation Rate - Jinpu Titanium (000545) saw a price increase of 9.81% with a turnover rate of 6.51%, latest price at 2.35 yuan, deviation rate of 9.12% [1] - Sanxiang Impression (000863) increased by 10.14% with a turnover rate of 3.85%, latest price at 4.02 yuan, deviation rate of 8.94% [1] - Houpu Co. (300471) rose by 8.78% with a turnover rate of 10.22%, latest price at 9.91 yuan, deviation rate of 7.94% [1] Additional Stocks with Notable Performance - Bojie Co. (002975) increased by 9.99% with a turnover rate of 3.33%, latest price at 32.81 yuan, deviation rate of 7.25% [1] - Hangxin Technology (300424) rose by 6.12% with a turnover rate of 11.08%, latest price at 15.78 yuan, deviation rate of 5.43% [1] - Other notable stocks include Zhonghang Shenfei (600760) and Hongye Futures (001236) with deviation rates of 4.48% and 3.52% respectively [1]